EcoDrugPlus

Integrin Beta 3a

Ensembl ID : ENSOTSG00005037668
Gene Symbol: ITGB3A
1 Cross references
195 Possible Orthologues:

Integrin Beta-3-Like

Ensembl ID : ENSOTSG00005037353
Gene Symbol: LOC112223770
3 Cross references
194 Possible Orthologues:

Integrin Subunit Alpha 4

Ensembl ID : ENSOTSG00005013236
Gene Symbol: ITGA4
1 Cross references
219 Possible Orthologues:

Integrin Subunit Alpha 4

Ensembl ID : ENSOTSG00005025288
Gene Symbol: ITGA4
3 Cross references
219 Possible Orthologues:

Integrin Subunit Alpha 5

Ensembl ID : ENSOTSG00005018778
Gene Symbol: ITGA5
1 Cross references
190 Possible Orthologues:

Integrin Subunit Alpha 5

Ensembl ID : ENSOTSG00005027056
Gene Symbol: ITGA5
1 Cross references
190 Possible Orthologues:

Integrin Subunit Alpha 5

Ensembl ID : ENSOTSG00005000680
Gene Symbol: ITGA5
3 Cross references
190 Possible Orthologues:

Integrin Subunit Beta 1

Ensembl ID : ENSOTSG00005041024
Gene Symbol: ITGB1
1 Cross references
223 Possible Orthologues:

Integrin Subunit Beta 1

Ensembl ID : ENSOTSG00005038806
Gene Symbol: ITGB1
1 Cross references
223 Possible Orthologues:

Integrin Subunit Beta 6

Ensembl ID : ENSOTSG00005026590
Gene Symbol: ITGB6
1 Cross references
204 Possible Orthologues:

Integrin Subunit Beta 7

Ensembl ID : ENSOTSG00005035084
Gene Symbol: ITGB7
1 Cross references
144 Possible Orthologues:

Integrin Subunit Beta 7

Ensembl ID : ENSOTSG00005033009
Gene Symbol: ITGB7
1 Cross references
133 Possible Orthologues:


PREMIER has received funding from the Innovative Medicines Initiative 2 Joint Undertaking (JU) under grant agreement No 875508. The JU receives support from the EU’s Horizon 2020 research and innovation programme and the European Federation of Pharmaceutical Industries and Associations (EFPIA). The views reflect only the authors’ perspective and the JU is not responsible for any use that may be made of the information this manuscript contains. Elements of the website have been developed under projects PREMIER and the Biocenter Finland Drug Discovery and Chemical Biology network. CSC-IT is thanked for providing computational resources. Content of the website is provided without guarantee for correctness. Data has been collected and integrated from multiple public sources, for the largest: FDA, HUGO Gene Nomenclature Committee, ChEMBL, IUPHAR/BPS guide to pharmacology, Reactome, UniProt, and Ensembl. Credit is given to Ensembl for collecting species images (provided under public domain licences such as Wikimedia and NHGRI).

PREMIER has received funding from the Innovative Medicines Initiative 2 Joint Undertaking (JU) under grant agreement No 875508. The JU receives support from the EU’s Horizon 2020 research and innovation programme and the European Federation of Pharmaceutical Industries and Associations (EFPIA). The views reflect only the authors’ perspective and the JU is not responsible for any use that may be made of the information this manuscript contains.

Elements of the website have been developed under projects PREMIER and the Biocenter Finland Drug Discovery and Chemical Biology network. CSC-IT is thanked for providing computational resources. Content of the website is provided without guarantee for correctness. Data has been collected and integrated from multiple public sources, for the largest: FDA, HUGO Gene Nomenclature Committee, ChEMBL, IUPHAR/BPS guide to pharmacology, Reactome, UniProt, and Ensembl. Credit is given to Ensembl for collecting species images (provided under public domain licences such as Wikimedia and NHGRI).